Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
AOD-9604 stands for "Anti-Obesity Drug-9604." Chemically, it is a synthetic 16-amino acid peptide that represents a modified fragment of the C-terminal region of the human growth hormone (HGH) polypeptide chain (specifically residues 176–191), with an additional tyrosine added at the N-terminus for stability.
Originally developed in Australia in the 1990s as a pharmaceutical treatment for obesity, its application has since expanded into sports medicine, body recomposition, and longevity circles.
Targeted Fat Metabolism: It is designed to mimic the lipolytic (fat-burning) power of natural HGH. It works by stimulating the beta-3 adrenergic receptors and activating hormone-sensitive lipase, which breaks down stored triglycerides in fat cells into usable energy.
Visceral Fat Reduction: It is particularly noted for its ability to help reduce visceral fat—the stubborn, "hard" fat found deep in the abdomen—without impacting the structural fat necessary for healthy organ padding.
Metabolic Safety (No Insulin Resistance): Unlike full-length HGH, AOD-9604 does not activate growth hormone receptors or increase IGF-1 levels. Consequently, it carries a much lower risk of causing glucose intolerance or insulin resistance, which are common side effects of regular HGH therapy.
Cartilage and Bone Health: Some clinical research and animal models suggest regenerative properties. It has been studied for its potential to repair cartilage damage and treat bone-related conditions like osteoarthritis, often by promoting the growth of new cartilage cells (chondrocytes).
Lean Physique Maintenance: Athletes and bodybuilders often utilize it during "cutting" phases. It allows for fat oxidation while preserving existing muscle mass, all without the systemic hormonal disruption (such as unwanted growth of other tissues) often associated with GH secretagogues.
Safety Profile: Clinical trials involving over 900 participants have shown it to be well-tolerated with a safety profile similar to a placebo. It has received "Generally Recognized as Safe" (GRAS) status for use as a nutraceutical ingredient in some regions, though it is not FDA-approved for medical weight loss.
AOD-9604 stands for "Anti-Obesity Drug-9604." Chemically, it is a synthetic 16-amino acid peptide that represents a modified fragment of the C-terminal region of the human growth hormone (HGH) polypeptide chain (specifically residues 176–191), with an additional tyrosine added at the N-terminus for stability.
Originally developed in Australia in the 1990s as a pharmaceutical treatment for obesity, its application has since expanded into sports medicine, body recomposition, and longevity circles.
Targeted Fat Metabolism: It is designed to mimic the lipolytic (fat-burning) power of natural HGH. It works by stimulating the beta-3 adrenergic receptors and activating hormone-sensitive lipase, which breaks down stored triglycerides in fat cells into usable energy.
Visceral Fat Reduction: It is particularly noted for its ability to help reduce visceral fat—the stubborn, "hard" fat found deep in the abdomen—without impacting the structural fat necessary for healthy organ padding.
Metabolic Safety (No Insulin Resistance): Unlike full-length HGH, AOD-9604 does not activate growth hormone receptors or increase IGF-1 levels. Consequently, it carries a much lower risk of causing glucose intolerance or insulin resistance, which are common side effects of regular HGH therapy.
Cartilage and Bone Health: Some clinical research and animal models suggest regenerative properties. It has been studied for its potential to repair cartilage damage and treat bone-related conditions like osteoarthritis, often by promoting the growth of new cartilage cells (chondrocytes).
Lean Physique Maintenance: Athletes and bodybuilders often utilize it during "cutting" phases. It allows for fat oxidation while preserving existing muscle mass, all without the systemic hormonal disruption (such as unwanted growth of other tissues) often associated with GH secretagogues.
Safety Profile: Clinical trials involving over 900 participants have shown it to be well-tolerated with a safety profile similar to a placebo. It has received "Generally Recognized as Safe" (GRAS) status for use as a nutraceutical ingredient in some regions, though it is not FDA-approved for medical weight loss.